Description and assessment of fitness-for-purpose of real-world data (RWD) sources on Duchenne Muscular Dystrophy for regulatory decision-making

26/09/2025
05/03/2026
EU PAS number:
EUPAS1000000748
Study
Ongoing
Study type

Study topic

Disease /health condition
Other

Study topic, other

Real World Data feasibility study

Study type

Not applicable

Scope of the study

Feasibility analysis
Validation of study variables (exposure outcome covariate)

Data collection methods

Secondary use of data
Study drug and medical condition

Medical condition to be studied

Duchenne muscular dystrophy
Population studied

Short description of the study population

Patients with Duchenne muscular dystrophy registered in a disease register (world-wide)

Estimated number of subjects

30000
Study design details

Study design

na

Main study objective

To identify a list of core variables to be used for future RWD studies in DMD patients with focus on the four regulatory research questions provided by EMA.

Summary results

The final core variable list for the fit-for-purpose assessment includes variables that are both scientifically
and clinically relevant to collect in real-world data sources, particularly disease registries. A “question-led”
approach was used to identify variables of interest enabling selection of variables ensuring focus on the
regulatory research question of interest.